Synlab Boards Won't Lean On Whether $1.3B Buyout Is Fair
The management and supervisory boards of medical laboratory company Synlab AG have said they will not be giving a recommendation on whether shareholders should accept or reject U.K.-based private equity firm...To view the full article, register now.
Already a subscriber? Click here to view full article